Keyphrases
6-hydroxydopamine (6-OHDA)
100%
C-Jun N-terminal Kinase Signaling
100%
Neurokinin-1 Receptor (NK1R)
100%
Senktide
100%
Dopaminergic Neurodegeneration
100%
6-Hydroxydopamine-lesioned Rats
71%
Substantia Nigra
42%
Phosphorylation
42%
Striatum
42%
Neurokinin 3 Receptor
42%
Parkinson's Disease
28%
Substantia Nigra Pars Compacta
28%
N-methyl-D-aspartate Receptor (NMDAR)
28%
C-Jun
28%
C-Jun N-terminal Kinase
28%
Neurokinin B
28%
NK3R
28%
In Vivo Model
14%
Neurodegeneration
14%
Immunohistochemistry
14%
Dopaminergic Neurons
14%
Tyrosine Hydroxylase
14%
Mitogen-activated Protein Kinase
14%
Receptor Agonist
14%
Immunoreactivity
14%
Protein Kinase
14%
Western Blotting
14%
Possible Mechanisms
14%
Rotation Measurement
14%
Apomorphine
14%
Pathway Activity
14%
Tyrosine Hydroxylase Expression
14%
Contralateral Rotations
14%
Rotation number
14%
Neuroscience
Oxidopamine
100%
Kinase
100%
Senktide
100%
Neurokinin 3 Receptor
100%
Dopaminergic
100%
Amino Terminal Sequence
100%
Substantia nigra
42%
Receptor
42%
Striatum
42%
Substantia Nigra Pars Compacta
28%
Parkinson's Disease
28%
Aspartic Acid
28%
Neurokinin
28%
Tyrosine Hydroxylase
28%
In Vivo
14%
Western Blot
14%
Immunohistochemistry
14%
Dopaminergic Neuron
14%
extracellular signal regulated kinase
14%
Receptor Agonists
14%
Nerve Cell Degeneration
14%
calcium activated,phospholipid dependent protein kinase
14%
Apomorphine
14%
Pharmacology, Toxicology and Pharmaceutical Science
Oxidopamine
100%
Phosphotransferase
100%
Dopamine Receptor Stimulating Agent
100%
Neurokinin 3 Receptor
100%
Senktide
100%
Receptor
42%
Tyrosine 3 Monooxygenase
28%
Parkinson's Disease
28%
Aspartic Acid
28%
Neurokinin
28%
Western Blot
14%
Mitogen Activated Protein Kinase
14%
calcium activated,phospholipid dependent protein kinase
14%
Apomorphine
14%
Nerve Cell Degeneration
14%
Neurokinin 3 Receptor Agonist
14%